Macquarie Group LTD Chimerix Inc Transaction History

Macquarie Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $6,094 - $9,292	-3,367 Reduced 32.38%	7,033 $20,000
Q3 2021 Nov 12, 2021	BUY	$5.94 - $8.75 $41,776 - $61,538	7,033 Added 208.88%	10,400 $64,000
Q2 2021 Aug 13, 2021	BUY	$7.54 - $9.79 $25,387 - $32,962	3,367 New	3,367 $27,000
Q1 2019 May 15, 2019	SELL	$1.79 - $3.12 $1,074 - $1,872	-600 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$3.58 - $4.9 $2,148 - $2,940	600 New	600 $2,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.